glycerylphosphorylcholine has been researched along with Hyperlipidemias in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujii, T; Izu, H; Matsubara, K; Okuda, M; Shibata, S | 1 |
| Gaertner, U; Johannes, KJ | 1 |
1 trial(s) available for glycerylphosphorylcholine and Hyperlipidemias
| Article | Year |
|---|---|
[Treatment of primary hyperlipoproteinemias. Comparison of N 041 with clofibrate].
Topics: Adult; Aged; Cholesterol; Chylomicrons; Clofibrate; Drug Combinations; Female; Glycerylphosphorylcholine; Humans; Hypercholesterolemia; Hyperlipidemias; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Middle Aged; Phosphatidylcholines; Triglycerides | 1976 |
1 other study(ies) available for glycerylphosphorylcholine and Hyperlipidemias
| Article | Year |
|---|---|
Anti-diabetic effect of S-adenosylmethionine and α-glycerophosphocholine in KK-A
Topics: Administration, Oral; Animals; Blood Glucose; Body Weight; Cholesterol; Diabetes Mellitus, Experimental; Disease Models, Animal; Drinking Water; Drug Combinations; Eating; Glycerylphosphorylcholine; Hyperglycemia; Hyperinsulinism; Hyperlipidemias; Hypoglycemic Agents; Leptin; Male; Mice; Mice, Transgenic; Obesity; S-Adenosylmethionine; Triglycerides | 2019 |